The host response to leishmania infection

Advances in Immunology

Volumn , Issue 74, 2000, Pages 275-317

  Solbach, Werner ^a   Laskay, Tamás ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LEISHMANIA; LEISHMANIASIS; PRIORITY JOURNAL; REVIEW;

EID: 0033991292     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (238)

1. Adler, S., and Theodor, O. (1927). The transmission of Leishmania tropica from artificially infected sandflies to man. An. Trop. Alcd. Parasitai. 2l, 89-110.
2. Aebischer, T., Moody, S. F., and Handman, E. (1993). Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61, 220-226.
3. Akufib, H., Maasho, K., and Howe, R. (1993). Natural and acquired resistance to Leishmania: Cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells. Clin. £xp. Immunol. 94,516-21.
4. Akuffo, H. O., Walford, C., and Nilsen, R. (1990). The pathogenesis of Leishmania aethiopica infection in BALB/c mice. Scand. ]. Immunol. 32, 103-10.
5. Albrecht, H. (1997). Redefining AIDS: towards a modification of the current AIDS case definition. Clin. Infect. Dis. 24, 64-74.
6. Alvar, J., Canavate, C., Gutierrez-Solar, B., Jimenez, M., Laguna, F., Lopez-Velez, R., Molina, R., and Moreno, J. (1997). Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clin. Microbiol. Rev. 10, 298-319.
7. Antoine, J. C., Prina, E., Lang, T., and Courret, N. (1998). The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol. 6, 392-401.
8. Assreuy, J., Cunha, F. Q., Epperlein, M., Noronha-Dutra, A., O'Donnell, C. A., Liew, F. Y., and Moncada, S. (1994). Production of nitric oxide and Superoxide by activated macrophages and killing of Leishmania major. Eur. ]. Immunol. 24, 672-676.
9. Atkinson, P. G., Blackvvell, J. M., and Barton, C. H. (1997). Nrampl locus encodes a 65 kDa interferon-gamma-inducible protein in murine macrophages. Biochem. J. 325, 779-86.
10. Barrai, A., Teixeira, M., Reis, P., Vinhas, V., Costa, J., Lessa, H., Bittencourt, A. L., Reed, 5.. Carvalho, E. M., and Barral-Netto, M. (1995). Transforming growth factor-β in human cutaneous leishmaniasis. Am. J. Pathol. 147, 947-954.
11. Beebe, A. M., Mauze, S., Schork, N. J., and Coffman, R. L. (1997). Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6. 551-557.
12. Beil, W. J., Meinardus-Hager, G., Neugebauer, D.-C., and Sorg, C. (1992). Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice.J. Leukoc. Biol. 52, 135-142.
13. Belkaid, Y., Butcher, B., and Sacks, D. L. (1998a). Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 28, 1389-400.
14. Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rovvton, E., Ribeiro, J., and Sacks, D. L. (1998b). Development of a natural model of cutaneous leishmaniasis: Powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188, 1941-53.
15. Berman, J. D. (1997). Human leishmaniasis: clinical,' diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24, 684-703.
16. Beverley, S. M., and Turco, S. J. (1998). Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol. 6, 35-40.
17. Blackvvell, J. M. (1996). Structure and function of the natural-resistance-associated macrophage protein (Nrampl), a candidate protein for infectious and autoimmune disease susceptibility. Mol. Med. Today 2, 205-11.
18. Blackwell, J. M., Black, G. F., Peacock, C. S., Miller, E. N., Sibthorpe, D., Gnananandha, D., Shaw, J. J., Silveira, F., Lins-Lainson, Z., Ramos, F., Collins, A., and Shaw, M. A. (1997). Immunogenetics of leishmanial and mycobacterial infections: The Belem Family Study. Philos. Trans. R. Soc. Land. B Biol. Sei. 352, 1331-45.
19. Blank, C., Fuchs, H., Rappersberger, K., Röllinghoff, M., and Moll, H. (1993). Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leisimania major. ]. Infect. Dis. 167, 418-425.
20. Bogdan, C. (1997). Of microbes, macrophages and NO. Behring Inst. Res. Commun. 99, 58-72.
21. Bogdan, C. (1998). The multiplex function of nitric oxide in (auto)immunity.J. Exp. Med. 187, 1361-5.
22. Bogdan, C., and Röllinghoff, M. (1998). The immune response to Leishmania: Mechanisms of parasite control and evasion. Int. J. Parasitai. 28, 121-34.
23. Bogdan, C., and Röllinghoff, M. (1996). The impact of the type 1 and type 2 T helper cell concept on novel vaccine design with emphasis on protection against Leishmania parasites. In "Concepts in Vaccine Development" (S. H. E. Kaufmann, ed.), pp. 205-242. De Gruyter, Berlin, New York.
24. Bozza, M., Soares, M. B., Bozza, P. T., Satoskar, A. R., Diacovo, T. G., Brombacher, F., Titus, R. G., Shoemaker, C. B., and David, J. R. (1998). The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10. Eur. J. Immunol. 28, 3120-7.
25. Bretscher, P. A., Wei, G., Menon, J. N., and Bielefeldt-Ohmann, H. (1992). Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257, 539-542.
26. Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K. P., and Mosser, D. M. (1995). Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155, 3102-11.
27. Brown, D. R., Fowell, D. J., Cony, D. B., Wynn, T. A., Moskowitz, N. H., Cheever, A. W., Locksley, R. M., and Reiner, S. L. (1996a). 02-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses.J. Exp. Med. 184,1295-1304.
28. Brown, D. R., Green, J. M., Moskowitz, N. H., Davis, M., Thompson, C. B., and Reiner, S. L. (1996b). Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184, 803-10.
29. Brown, J., Titus, R., Nabavi, N., and Glimcher, L. (1996c). Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J. Infect. Dis. 174, 1303-1308.
30. Bryceson, A. D. M. (1996). Leishmaniasis. In "Manson's Tropical Diseases," 20th ed. (G. C. Cokk, éd.), pp. 1213-1246. Saunders, London, Philadelphia, Toronto.
31. Buchmüller-Rouiller, Y., and Mauël, J. (1987). Inpairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect. Immun. 55, 587-593.
32. Butcher, E. C., and Picker, L. J. (1996). Lymphocyte homing and homeostasis. Science 272, 60-6.
33. Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G., and Maliszewski, C. R. (1996). CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-289.
34. Carini, A. (1911). Leishmaniose de la muqueuse rhino-bucco-pharyngée. Bull Soc. PatJiol. Exot. 4, 289-291.
35. Carrera, L., GazzineUi, R. T., Badolato, R., Hieny, S., Müller, W., Kühn, R., and Sacks, D. L. (1996). Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183, 515-26.
36. Conceicao-Silva, F., Hahne, M., Schroter, M., Louis, J., and Tschopp, J. (1998). The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28, 237-45.
37. Cony, D. B., Reiner, S. L., Linsley, P. S., and Locksley, R. M. (1994). Differential effects of blockade of CD28-B7 on the development of Thl orTh2 effector cells in experimental leishmaniasis. J. Immunol. 153, 4142-8.
38. Cox, F. E. (1997). Designer vaccines for parasitic diseases. Int. J. Parasitai 27, 1147-57.
39. Cunningham, D. D. (1885). On the presence of peculiar parasitic organs in the tissue of a specimen of Delhi boil. Sei. Mem. Med. Officers Army India 1, 21-31.
40. de Souza-Leao, S., Lang, T., Prina, E. Hellio, R., and Antoine, J. C. (1995). Intracellular Leishmania amazonensis amastigotes internalize and degrade MHCcIass II molecules of their host cells. J. Cell. Sei. 108, 3219-3231.
41. Demant, P., Lipoldova, M., and Svobodova, M. (1996). Resistance to Leishmania major in mice. Science 274, 1392.
42. Desjardins, M., and Descoteaux, A. (1997). Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan J. Exp. Med. 185, 2061-8.
43. Desjeax, P. (1996). Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14, 417-423.
44. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Rollinghoff, M., Gresser, I., and Bogdan, C. (1998). Type 1 interferon (IFN α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87.
45. Ding, A. H., Nathan, C. F., and Stuehr, D. J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141,2407-2412.
46. Doherty, T. M., and Coffman, R. L. (1996). Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitai. 84, 124-35.
47. Dominguez, M., and Torano, A. (1999). Immune adherence-mediated opsonophagocytosis: The mechanism of Leishmania infection. J. Exp. Med. 189, 25-35.
48. Donnelly, K. B., Lima, H. C., and Titus, R. G. (1998). Histologie characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate. J. Parasitai. 84, 97-103.
49. Donovan, C. (1903). On the possibility of occurence of trypanosomiasis in India. Br. Med. J. 2, 79.
50. Etges, R., and Müller, I. (1998). Progressive disease or protective immunity to Leishmania major infection: The result of a network of stimulatory and inhibitory interactions. J. Mol. Med. 76, 372-90.
51. Evans, T. G., Reed, S. S., and Hibbs, J. B., Jr. (1996). Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide. Am. J. Trop. Med. Hyg. 54, 4S6-9.
52. Evans, T. G., Thai, L., Granger, D. L., and Hibbs Jr., J. B. (1993). Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151, 907-915.
53. Fruth, U., Solioz, N., and Louis, J. A. (1993). Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol. 150, 1857-1864.
54. Ghalib, H. W., Whittle, J. A., Kubin, M., Hashim, F. A., el-Hassen, A. M., Grabstein, K. H., Trinchieri, G., and Reed, S. (1995). IL-12 enhances Thl-type responses in human Leishmania donovani infections. J. Immunol. 154, 4623-4629.
55. Ghosh, K. N., and Mukhopadhyay, J. (1998). The effect of anti-sandfly saliva antibodies on Phlebotomus argentipes and Leishmania donovani. Int. J. Parasitai. 28, 275-81.
56. Giorgio, S., Linares, E., Ischiropoulos, H., Von Zuben, F. J., Yamada, A., and Augusto, O. (1998). In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotyrosine is not impaired during murine leishmaniasis. Infect. Immun. 66,807-14.
57. Girard, J. P., and Springer, T. A. (1995). High endothelial venules (IIEVs): Specialized endothelium for lymphocyte migration. Immunol. Today 16, 449-57.
58. Gomes, N. A., Barreto-de-Souza, V., Wilson, M. E., and DosReis, G. A. (1998). Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway. J. Infect. Dis. 178, 1847-51.
59. Gorak, P. M., Engwerda, C. R., and Kaye, P. M. (199S). Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28, 687-95.
60. Gorham, J. D., Guler, M. L., and Murphy, K. M. (1997). Genetic control of interleukin 12 responsiveness: Implications for disease pathogenesis.J. Mol. Med. 75, 502-11.
61. Gorham, J. D., Guler, M. L., Fenoglio, D., Gubler, U., and Murphy, K. M. (1998). Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells.J. Immunol. 161,1664-70.
62. Gorham, J. D., Guler, M. L., Steen, R. G., Mackey, A. J., Daly, M. J., Frederick, K., Dietrich, W. F., and Murphy, K. M. (1996a). Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sei. USA 93, 12467-72.
63. Gorham, J. D., Guler, M. L., Steen, R. G., Mackey, A. J., Daly, M. ]., Frederick, K., Dietrich, W. F., and Murphy, K. M. (1996b). Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Immunology 93,12467-12472.
64. Govoni, G., and Gros, P. (1998). Macrophage NRAMP1 and its role in resistance to microbial infections. Inflation. Res. 47, 277-84.
65. Green, S. ]., Meltzer, M. S., Hibbs Jr., J. B., and Nacy, C. A. (1990). Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144, 278-286.
66. Greil, J., Bodendorfer, B., Röllinghoff, M., and Solbach, W. (1988). Application of recombinant granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis. Eur. J. Immunol. 18, 1527-1533.
67. Guler, M. L., Jacobson, N. G., Gubler, U., and Murphy, K. M. (1997). T cell genetic background determines maintenance of IL-12 signaling. J. Immunol. 159, 1767-1774.
68. Gurunathan, S., Prussin, C., Sacks, D. L., and Seder, R. A. (1998). Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4,1409-15.
69. Gurunathan, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N., and Seder, R. A. (1997). Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. ]. Exp. Med. 186, 1137-47.
70. Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., and Wagner, H. ( 1998). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230-40.
71. Handman, E., Ceredig, R., and Mitchell, G. F. (1979). Murine cutaneous leishmaniasis: Disease pattern in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust. J. Exp. Biol. Med. Sei. 57, 9-29.
72. Heinzel, F. P., Rerko, R. M., Ahmed, F., and Pearlman, E. (1995). Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155, 730-739.
73. Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., and Locksley, R. M. (1989). Reciprocal expression of interferon yx or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.J. Exp. Med. 169,59-72.
74. Hermoso.T., Fishelson, Z., Decker, S. L, Hirschberg, K., and Jaffe.C. L. (1991). Leishmanial protein kinases phosphorylate components of the complement system. EMBO J. 10, 4061-7.
75. Hey, A. S., Theander, T. G., Hviid, L., Hazrati, S. M., Kemp, M., and Kharazmi, A. (1994). The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells.J. Immunol. 152, 4542-8.
76. Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F., Louis, J. A., and Launois, P. (1998). The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major downregulates IL-12 receptor /32-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161, 6156-6163.
77. Hommel, M., Jaffe, C. L., Travi, B., and Milon, G. (1995). Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann. Trop. Med. Parasitai. 89 SuppI 1, 55-73.
78. Howard, J. G. (1985). Host immunity to leishmaniasis. In "Leishmaniasis" (K.-P. Chang and R. S. Bray, eds.), pp. 139-162. Elsevier (Biomédical Division), London.
79. Howard, J. G., Hale, C., and Chan-Liew, W. L. (1980). Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 2, 203-214.
80. Howard, J. G., Hale, C., and Liew, F. Y. (1982). Genetically determined response mechanisms to cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hijg. 76, 152-154.
81. Hsieh, C.-S., Macatonia, S. E., O'Garra, A., and Murphy, K. (1995). T cell genetic background determines default T helper phenotype development in vitro.J. Exp. Med. 181,713-721.
82. Huang, F. P., Niedbala, W., Wei, X. Q., Xu, D., Feng, G. J., Robinson, J. H., Lam, C., and Liew, F. Y. (1998a). Nitric oxide regulates Thl cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28, 4062-70.
83. Huang, F. P., Xu, D., Esfandiari, E. O., Sands, W., Wei, X. Q., and Liew, F. Y. (1998b). Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Thl responses, and enhanced nitric oxide production.J. Immunol. 160, 4143-7.
84. Ilg, T., Craik, D., Currie, G., Multhaup, G., and Bacic, A. (199S). Stage-specific proteophosphoglycan from Leishmania mexicana amastigotes. Structural characterization of novel mono-, di-, and triphosphorylated phosphodiester-linked oligosaccharides. J. Biol. Chem. 273, 13509-23.
85. Ilg, T., Harbecke, D., and Overath, P. (1993). The lysosomal gp63-related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimum. FEES Lett. 327, 103-107.
86. Ilg, T., Stierhof, Y. D., Mac Conville, M. J., and Overath, P. (1995). Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes. Eur. J. Cell. Biol. 66, 205-215.
87. lonac, M., Laskay, T., Labahn, D., Geisslinger, G., and Solbach, W. (1997). Improved technique for cannulation of the murine thoracic duct: a valuable tool for the dissection of immune responses. J. Immunol. Methods 202, 35-40.
88. Ismail, S. O., Skeiky, Y. A. W., Bhatia, A., Omara-Opyene, L. A., and Gedamu, L. (1994). Molecular cloning, characterization, and expression in Escherichia coli of iron Superoxide dismutase cDNA from Leishmania donovani chagasi. Infect. Immun. 62, 657-664.
89. Jackson, T. S., Lerner, E., Weisbrod, R. M., Tajima, M., Loscalzo, J., and Keaney, J. F., Jr. (1996). Vasodilatory properties of recombinant maxadilan. Am. J. Phijsiol. 271,11924-30.
90. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. G., and Vogel, J. C. (1998). Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Thl responses by immunostimulatory DNA. J. Immunol. 161, 3042-9.
91. Jardim, A., Alexander, J., Teh, H. S., Ou, D., and Olafson, R. W. (1990). Immunoprotective Leishmania major synthetic T cell epitopes. J. Exp. Med. 172, 645-8.
92. Ju, S. T., Gui, IL, Panka, D. J., Ettinger, R., and Marshak-Rothstein, A. (1994). Participation of target Fas protein in apoptosis pathway induced by CD4+ Thl and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sei. USA 91, 4185-9.
93. Julia, V., Rassoulzadegan, M., and Glaichenhaus, N. (1996). Resistance to Leishmania major induced by tolerance to a single antigen. Science 274, 421-3.
94. Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., and Kikutani, H. (1996). Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-81.
95. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T., and Vilcek, J. (1994). Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 236, 1612-1615.
96. Kaye, P. M. (1995). Costimulation and the regulation of antimicrobial immunity. Immunol. Today 16, 423-427.
97. Kemp, M., Theander, T. G., and Kharazmi, A. (1996). The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol. Today 17, 13-6.
98. Kima, P. E., Soong, L., Chicharro, C., Ruddle, N. H., and Me Mahon-Pratt, D. (1996). Leis/imam'a-infected macrophages sequester endogenously synthesized parasite antigens for presentation to CD4+ T cells. Eur. J. Immunol 26, 3163-3169.
99. Kopf, M., Brombacher, F., Köhler, G., Kienzle, G., Widmann, K.-H., Lefrang, K., Humborg, C., Ledermann, B., and Solbach, W. (1996). IL-4 deficient mice resist infection with Leishmania major. J. Exp. Med. 184, 1127-1136.
100. Kropf, P., Etges, R., Schöpf, L., Chung, C., Sypek, J., and Muller, I. (1997). Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4. J. Immunol. 159, 3434-43.
101. Krummel, M. F., and Allison, J. P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. E.xp. Med. 182, 459-65.
102. Kubar, J., Marry, P., Lelievre, A., Quaranta, J. F., Staccini, P., Caroli-Bosc, C., and Le Fichoux, Y. (1998). Visceral leishmaniosis in HIV-positive patients: Primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 12, 2147-53.
103. Kumar, V., Hackett, J., Jr., Tutt, M. M., Garni-Wagner, B. A., Kuziel, W. A., Tucker, P. W., and Bennett, M. (1989). Natural killer cells and their precursors in mice with severe combined immunodeficiency. Curr. Topics Microbiol. Immunol. 152, 47-52.
104. Lainson, R., and Shaw, J. J. (1987). Evolution, classification and geographical distribution. In "The Leishmaniases in Biology and Medicine" (W. Peters and R. Killick-Kendrick, eds.), vol. 1, pp. 1-120. Academic Press, Orlando.
105. Lang, T., Hellio, R., Kaye, P. M., and Antoine, J. C. (1994). Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J. Cell Set. 107, 2137-50.
106. Lang, T., Prina, E., Sibthorpe, D., and Blackwell, J. M. (1997). Nrampl transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: Influence on antigen processing and presentation. Infect. Immun. 65, 380-6.
107. Laskay, T., Diefenbach, A., Rollinghoff, M., and Solbach, W. (1995). Early parasite containment is decisive for resistance to LcisJwiania major infection. Etir. J. Immunol. 25,2220-7.
108. Laskay, T., Mariam, II. G., Berhane, T. Y., Fehniger, T. E., and Kiessling, R. (1991). Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection. Clin. Microbiol 29, 757-63.
109. Laskay, T., Rollinghoff, M., and Solbach, W. (1993). Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur.J. Immunol. 23,2237-2241.
110. Laskay, T., Vester, B., and Solbach, W. (1998). Natural killer (NK) cells are the first lymphocytes recruited to the site of infection with Leishmania major. In "The 10th International Congress of Immunology" (G. P. Talwar, I. Nath, N. K. Ganguly, and H. V. S. Rao, eds.), pp. 913-917. Monduzzi Editore, Bologna.
111. Laskay, T., Wittmann, I., Diefenbach, A., Rollinghoff, M., and Solbach, W. (1997). Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes. J. Immunol. 158, 1246-53.
112. Launois, P., Maillard, I., Pingel, S., Swihart, K., Xénarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R., and Louis, J. A. (1997a). IL-4 rapidly produced by V/34 Va8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549.
113. Launois, P., Ohteki, T., Swihart, K., MacDonald, II. R., and Louis, J. A. (1995). In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur. J. Immunol. 25, 3298-3307.
114. Launois, P., Swihart, K. G., Milon, G., and Louis, J. A. (1997b). Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unrespon- siveness. J. Immunol. 158, 3317-3324.
115. Leclercq, V., Lebastard, M., Belkaid, Y., Louis, J., and Milon, G. (1996). The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice. A tissuedependent pattern controlled by the Lsh and MIIC loci.J. Immunol. 157, 4537-4545.
116. Leishman, V. B. (1903). On the possibility of occurence of trypanosomiasis in India. Br. Med. J. 1, 1251-1254.
117. Lerner, E. A., and Shoemaker, C. B. (1992). Maxadilan. Cloning and functional expression of the gene encoding this potent vasodilator peptide. J. Biol. Cliem. 267, 1062-6.
118. Lerner, E. A., Ribeiro, J. M., Nelson, R. J.,and Lemer, M. R. (1991). Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J. Biol Chem. 266, 11234-11236.
119. Levick, M. P., Tetaud, E., Fairlamb, A. H., and Blackwell, J. M. (1998). Identification and characterisation of a functional peroxidoxin from Leishmania major. Mol. Biochem. Parasitai. 96, 125-37.
120. Li, J., Hunter, C. A., and Farrell, J. P. (1999). Anti-TCF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162, 974-9.
121. Li, S., Wilson, M. E., and Donelson, J. E. (1996). Leishmania chagasi: a gene encoding a protein kinase with a catalytic domain structurally related to MAP kinase kinase. Exp. Parasitai. 82, 87-96.
122. Dew, F. Y., Millott, S., Parkinson, C., Palmer, R. M. J., and Moncada, S. (1990). Macrophage killing of LcisJimania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144, 4794-4797.
123. Uevv, F. Y., Wei, X. Q., and Proudfoot, L. (1997). Cytokines and nitric oxide as effector molecules against parasitic infections. Philos. Trans. R. Soc. Land. B Biol. Sei. 352,1311-5.
124. Lima, H. C., and Titus, R. G. (1996). Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect. Immun. 65, 5442-5445.
125. Locksley, R. M., Heinzel, F. P., Funkhäuser, J. E., Nelson, C. S., and Sadick, M. D. (19S8). Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote. Infect. Immun. 56, 336-342.
126. Locksley, R. M., Heinzel, F. P., Sadick, M. D., Holaday, B. J., and Gardner, K. D. (1987). Murine cutaneous leishmaniasis. Susceptibility correlates with differential expression of helper T cell subsets. Ann. Inst. Pastetir/Immitnol. 138, 744-749.
127. Lohoff, M., Ferrick, D., Mittriicker, H.-W., and al., e. (1997). Interferon regulatory factor- 1 is required for a T helper 1 immune response in vivo. Immunity G, 681-689.
128. Maasho, K., Sanchez, F., Schurr, E., Hailu, A., and Akuffo, H. (1998). Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect. Immun. 66, 2698-704.
129. Magill, A. J., Grögl, M., Gasser Jr., R. A., Sun, W., and Oster, C. N. (1993). Visceral infection caused by Leishmania tropica in veterans of operation desert storm. N. Engl. J. Med. 328, 1383-1387.
130. Mattner, F., Di Padova, K., and Alber, G. (1997). Interleukin-12 is indespensable for protective immunity against Leishmania major. Infect. Immun. 65, 4378-4383.
131. Mattner, F., Magrain, J., Ferrante, J., Lounois, P., Di Padova, K., Behin, R., Gately, M. K., Louis, J. A., and Alber, G. (1996). Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leislunania major and'mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559.
132. Mbow, M. L., Bleyenberg, J. A., Hall, L. R., and Titus, R. G. (199S). Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Thl, but up-regulates a Th2, response in mice infected with Leishmania major. J. Immunol. 161, 5571-7.
133. McConville, M. J., and Ralton, J. E. (1997). Developmentally regulated changes in the cell surface architecture of Leishmania parasites. Behring Inst. Mitt. 99, 34-43.
134. Medina-Acosta, E., Karess, R. E., Schwartz, R., and Russell, D. G. (1989). The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed an localized in the amastigote stage. Mol. Biochem, Parasitai. 37, 263-274.
135. Menon, J. N., and Bretscher, P. A. (1998). Parasite dose determines the Thl/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur. J. Immunol. 28, 4020-8.
136. Milon, G., Del Giudice, G., and Louis, J. A. (1995). Immunobiology of experimental cutaneous leishmaniasis. Parasitai. Today 11, 244-247.
137. Mirkovich, A. M., Galelli, A., Allison, A. C., and Modabber, F. Z. (1986). Increased myelo- poiesis during Leishmania major infection in mice: generation of "safe targets," a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 164, 1-7.
138. Mitchell, G. F. (1983). Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several Fl hybrids infected with Leishmania tropica major. J. Immunogenet. 10, 395-412.
139. Mitchell, G. F., Curtis, J. M., Handman, E., and McKenzie, I. F. G. (19SO). Cutaneous leishmaniasis in mice: Disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust. ]. Exp. Biol. Med. Sei. 58, 521-532.
140. Modabber, F. (1995). Vaccines against leishmaniasis. Ann. Trop. Med. Parasitai. 89 Suppl 1, 83-8.
141. Moll, H., Flohe, S., and Röllinghoff, M. (1995). Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25, 693-699.
142. Moore, K. J., and Matlashewski, G. (1994). Intracellular infection by Leislunania donovani inhibits macrophage apoptosis. J. Immunol. 152, 2930-7.
143. Mosmann, T. R., and Coffman, R. L. (1989). Thl and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Anna. Rev. Immunol. 7, 145-173.
144. Mosser, D. M., and Rrittingham, A. (1997). Leishmania, macrophages and complement: A tale of subversion and exploitation. Parasitologij 115, S9-23.
145. Mougneau, E., Altare, F., Waldl, A. E., Zheng, S., Coppola, T., Wang, Z. E., Waldmann, R., Locksley, R. M., and Glaichenhaus, N. (1995). Expression cloning of a protective Leishmania antigen. Science 268, 563-6.
146. Murphy, M. L., Cotterell, S. E., Gorak, P. M., Engwerda, C. R., and Kaye, P. M. (1998). Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 161, 4153-60.
147. Murphy, M. L., Engwerda, C. R., Gorak, P. M., and Kaye, P. M. (1997). B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol. 159, 4460-6.
148. Murray, H. W. (1994). Interferon-gamma and host antimicrobial defense: current and futureclinical applications. Am. J. bled. 97, 459-67.
149. Murray, H. W., and Nathan, C. F. (1999). Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of visceral Leishmania donovani. J. Exp. Med. 189, 1741-1746.
150. Nabors, G. S., Nolan, T., Croop, W., U, J., and Farrell, J. P. (1995). The influence of the site of parasite inoculation on the development of Thl and Th2 type immune responses in (BALB/c X C57BIV6)F1 mice infected with Leishmania major. Parasite Immunol. 17, 569-579.
151. Nashleanas, M., Kanaly, S., and Scott, P. (1998). Control of Leishmania major infection in mice lacking TNF receptors. J. Immunol. 160, 5506-13.
152. Noben-Trautli, N., Kröpf, P., and Müller, I. (1996). Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271, 987-990.
153. Palma, G. I., and Saravia, N. G. (1997). In situ characterization of the human host response to Leishmania panamensis. Am. J. Dermatopathol. 19, 585-90.
154. Passwell, J. H., Shor, R., Smolen, J., and Jaffe, C. L. (1994). Infection of human monocytes y Leishmania results in a defective oxidative burst. Int. J. Exp. Pathol. 75, 277-284.
155. Pearson, R. D., and de Queiroz, S. (1996). Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22, 1-13.
156. Pearson, R. D., and Steigbigel, R. T. (1981). Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes.J. Immunol. 127, 1438-1443.
157. Peters, C., Stierhof, Y. D., and Hg, T. (1997). Proteophosphoglycan secreted by Leishmania mexicana amastigotes causes vacuole formation in macrophages. Infect. Immun. 65,783-6.
158. Pinelli, E., Rutten, V., Bruysters, M., Moore, P. F., and Ruitenberg, E. J. (1999). Compensation for decreased expression of B7 molecules on leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production. Infect. Immun. 67, 237-43.
159. Prina, E., Jouanne, C., de Souza Lao, S., Szabo, A., Guillet, J.-G., and Antoine, J.-C. (1993). Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J. Immunol. 151, 2050-2061.
160. Prina, E., Lang, T., Glaichenhaus, N., and Antoine, J. C. (1996). Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.J. Immunol. 156,4318-27.
161. Probst, P., Skeiky, Y. A., Sleeves, M., Gervassi, A., Grabstein, K. H., and Reed, S. G. (1997). A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factoralpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur. J. Immunol. 27, 2634-2642.
162. Proudfoot, L., Nikolaev, A. V., Feng, G.-J., and al., e. (1996). Regulation of the expression of nitric oxide synthase and Leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages, froc. Natl. head. Set. USA 93,10984-109S9.
163. Proudfoot, L., O'Donnell, C. A., and Dew, F. Y. (1995). Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Ear. J. Immunol. 25, 745-750.
164. Puentes, S. M., Suva da, R. P., Sacks, D. L., Hammer, C. H., and Joiner, K. A. (1990). Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. Immunol. 145, 4311-4316.
165. Reiner, S. L., and Locksley, R. M. (1995). The regulation of immunity to Leishmania major. Anna. Rev. Immunol. 13, 151-77.
166. Reiner, S. L., Wang, Z.-E., Hatam, F., Scott, P., and Locksley, R. M. (1993). Till and Th2 cell antigen receptors in experimental leishmaniasis. Science 259, 1457-1460.
167. Reiner, S. L., Zlieng, S., Wang, Z. -E., Stowring, L., and Locksley, R. M. (1994a). Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T-cells during initiation of infection. J. Exp. Med. 179, 447-456.
168. Reiner, S. L., Zheng, S., Wang, Z.-E., Slow-ring, L., and Locksley, R. M. (1994b). Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179, 447-456.
169. Ritter, U., Moll, IL, Laskay, T., Bröcker, E.-B., Velazco, O., Becker, I., and Gillitzer, R. (1996). Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 173, 699-709.
170. Rittig, M. G., Burmester, G. R., and Krause, A. (1998a). Coiling phagocytosis: When the zipper jams, the cup is deformed. Trends Microbiol. 6, 384-8.
171. Rittig, M. G., Schroppel, K., Seack, K. II., Sander, U., N'Diaye, E. N., Maridonneau-Parini, L, Solbach, W., and Bogdan, C. (1998b). Coiling phagocytosis of trypanosomatids and fungal cells. Infect. Immun. 66, 4331-9.
172. Roberts, L. J., Baldwin, T. M., Curtis, J. M., Handman, E., and Foote, S. J. (1997). Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J. Exp. Med. 185, 1705-1710.
173. Rodrigues, V., Jr., Santana da Suva, J., and Campos-Neto, A. (1998). Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66, 1233-6.
174. Romani, L., Puccetti, P., and Bistoni, F. (1997). Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10, 611-636.
175. Rosenthal, L. A., Sutterwala, F. S., Kehrli, M. E., and Mosser, D. M. (1996). Leishmania Hia/or-human macrophage interactions: Cooperation between Mac- 1 (CDllb/CD18) and complement receptor type l (CD35) in promastigote adhesion. Infect. Immun. 64, 2206-15.
176. Russell, D. G., and Talamas-Rohana, P. (1991). Leishmania and the macrophage: A marriage of inconvenience. Immunol. Today 10, 328-333.
177. Saar, Y., Ransford, A., Waldman, E., Mazareb, S., Amin-Spector, S., Plumblee, J., Turco, S. J., and Zilberstein, D. (1998). Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol. Biochem. Parasitai. 95, 9-20.
178. Sacks, D. L., and Perkins, P. (1984). Identification of an infective stage of Leishmania promastigotes. Science 223, 1417-1419.
179. Sacks, D. L., Pimenta, P. F., McConville, M. J., Schneider, P., and Turco, S. J. (1995). Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J. Exp. Mcd. 181, 685-97.
180. Salia, B., Chattopadhyay, S., Germond, R., Harlan, D. M., and Perrin, P. J. (1998). CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection. Eur. J. Immunol. 28, 4213-20.
181. Saha, B., Das, G., Vohra, H., Ganguly, N. K., and Mishra, G. G. (1995). Macrophage-T cell interaction in experimental visceral leishmaniasis: Failure to express costimulatory molecules on Leishmania infected macrophages and its implications in the suppression of cell-mediated immunity. Eur. J. Immunol. 25, 2492-2498.
182. Sarih, M., Souvannavong, V., and Adam, A. (1993). Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Bioplitjs. Res. Commun. 191, 503-8.
183. Sartori, A., Oliveira, M. A. P., Scott, P., and Trinchieri, G. (1997). Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol. 159, 2849-2857.
184. Satoskar, A., Bluethmann, H., and Alexander, J. (1995). Disruption of the murine interleukin4 gene inhibits disease progression during Leishmania mexicana infection, but does not increase control of Leishmania donouani infection. Infect. Immun. 63, 4894-4899.
185. Scharton, T. M., and Scott, P. (1993). Natural killer cells are a source of interferon fj, that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
186. Scharton-Kersten, T., and Scott, P. (1995). The role of the innate immune response in Thl cell development following Leishmania major infection.J. Leukoc. Biol. 57, 515-522.
187. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G., and Scott, P. (1995a). IL-12 is required for natural killer cell activation and subsequent T helper I cell development in experimental leishmaniasis. J. Immunol. 154, 5320-5330.
188. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G., and Scott, P. (1995b). IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154, 5320-5330.
189. Schlagenhauf, E., Etges, R., and Metcalf, P. (1998). The crystal structure of the Leishmania major surface proteinase leishmanolysin (gp63). Structure 6, 1035-46.
190. Schlein, Y., Jacobson, R. L., and Messer, G. (1992). Leishmania infections damage the feeding mechanism of the sand fly vector and implement parasite transmission by bite. Proc. Natl. Acad. Set. USA. 89, 9944-9948.
191. Schubach, A., Haddad, F., Neto, M. P.-O., Degrave, W., Pirmez, C., Grimaldi Jr., G., and O., F. (1998a). Detection of Leishmania DNA by polymerase chain rection in scars of treated human patients.J. Infect. Dis. 178, 911-914.
192. Schubach, A., Marzochi, M. C., Cuzzi-Maya, T., Oliveira, A. V., Araujo, M. L., Oliveira, A. L., Pacheco, R. S., Momen, H., Conceicao-Silva, F., Coutinho, S. G., and Marzochi, K. B. (199Sb). Cutaneous scars in American tegumentary leishmaniasis patients: A site of Leislwiania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am. J. Trop. Med. Hyg. 58, 824-7.
193. Scott, P., Caspar, P., and Slier, A. (1990). Protection against Leishmania major in BALE/ c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J. Immunol. 144, 1075-1079.
194. Searle, S., Bright, N. A., Roach, T. L, Atldnson, P. G., Barton, C. H., Meloen, R. H., and Blackwell, J. M. (1998). Localisation of Nrampl in macrophages:Modulation with activation and infection.J. Cell. Sei. Ill, 2855-66.
195. Seay, M. B., Heard, P. L., and Chaudhuri, G. (1996). Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun. 64, 5129-37.
196. Seder, R. A., Paul, W. E., Davis, M. M., and de St. Groth, B. F. (1992). The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.J. Exp. Med. 176, 1091-1098.
197. Skeiky, Y. A., Kennedy, M., Kaufman, D., Borgess, M. M., Guderian, J. A., Scholler, J. K., Ovendale, P. J., Picha, K. S., Morrissey, P. J., Grabstein, K. H., Campos-Neto, A., and Reed, S. G. (1998). LelF: A recombinant Leishmania protein that induces an IL-12 mediated Till c)toldne profile./ Imnwnol. 161, 6171-6179.
198. Solbach, W., and Laskay, T. (1996). Evasion strategies of Leishmania. In "Cutaneous Leishmaniasis: Molecular Mechanisms in the Pathogenesis" (F. Tapia, éd.), pp. 25-35. Landes, Austin.
199. Soong, L., Xu, J. C., Grewal, I. S., Kima, P., Sun, J., Longley, B. J., Jr., Ruddle, N. H., McMahon-Pratt, D., and Flavell, R. A. (1996). Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-73.
200. Sorensen, A. L., Hey, A. S., and Kharazmi, A. (1994). Leishmania major surface protease gp63 interferes with the function of human monocytes and neutrophils In vitro. APMIS 102, 265-271.
201. Spanvasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Elhvart, J. W., and Wagner, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-54.
202. Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., and Bogdan, C. (1996). Reactivation of latent kleishmaniasis by inhibition of inducible nitric oxide synthase.J. Exp. Med. 183, 1501-1514.
203. Stenger, S., Thüring, H., Röllinghoff, M., and Bogdan, K. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. }. Exp. Med. 180, 783-793.
204. Stierhof, Y. D., Wiese, M., Hg, T., Overath, P., Haner, M., and Aebi, U. (1998). Structure of a filamentous phosphoglycoprotein polymer: The secreted acid phosphatase of Leishmania mexicana. J. Mol. Biol. 282, 137-48.
205. Sunderkötter, C., Kunz, M., Steinbrink, K., Meinardus-Hager, G., Goebeler, M., Bildau, H., and Sorg, K. (1993). Resistance of mice to experimental Leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151, 4891-4901.
206. Suttenvala, F. S., Rosenthal, L. A., and Mosser, D. M. (1996). Cooperative between CR1 (CD35) and CR3 (CD llb/CD18) in the binding of complement-opsonized particles. J. Leukoc. Biol. 59, 883-90.
207. Swihart, K., Fruth, U., Messmer, N., Hug, K.,=Behin, R., Huang, S., Del Giudice, G., Aguet, M., and Louis, J. A. (1995). Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.J. Exp. Med. 181, 961-71.
208. Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J. Sieburth, D. S., Wolf, S. F., and Schaub, R. G. (1993). Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
209. Tanaka, T., Hu-Li, J., Seder, R. A., de St. Groth, B. F., and Paul, W. E. (1993). Interleukin 4 suppresses interleukin 2 and interferon y production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Nail. head. Sei. USA. 90, 5914-5918.
210. Theodos, C. M., Ribeiro, J. M., and Titus, R. G. (1991). Analysis of enhancing effect of sand fly saliva on Leislimania infection in mice. Infect. Immun. 59, 1592-8.
211. Titus, R. G., and Ribeiro, J. M. C. (1988). Salivary gland lysates from sand fly Lytzmyia longipalpis enhances Leishmania infectivity. Science 239, 1306-1308.
212. Titus, R. G., Ceredig, R., Cerottini, J.-C. and Louis, J. A. (1985). Therapeutic effect of anti- L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice.J. Immunol 135, 2108-2114.
213. Trinchieri, G. (1995). Interleukin 12: a proinflammatory cytokine vith immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Anna. Rev. Immunol. 13, 251-276.
214. Turco, S. J., and Descoteaux, A. (1992). The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol, 46, 65-94.
215. Vianna, G. (1912). Tratamento da leishmaniose tegumentar por injeccoes intravenosa de tartaro emetico. Ann. do 7. Congresso Brasileim de Medicina e Cirurgia 4, 426-428.
216. Vidai, S., Tremblay, M. L., Govoni, G., Gauthier, S., Sebastian!, G., Malo, D., Skamene, E., Olivier, M., Jothy, S., and Gros, P. (1995). The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J. Exp. Med. 182, 655-66.
217. Vidai, S. M., Malo, D., Vogan, K., Skamene, E., and Gros. P. (1993). Natural resistance to infection with intracellular parasites: Isolation of a candidate for Beg. Cell 73, 469-85.
218. Vieira, L. Q., Goldschmidt, M., Nashleanas, M., Pfeffer, K., Mak, T., and Scott, P. (1996). Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J. Immunol. 157, 827-35.
219. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q.-W., and Nathan, C. (1993). Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-/?. J. Exp. Med. 178, 605-613.
220. von der Weid, T., Beebe, A. M., Roopenian, D. C., and Coffman, R. L. (1996). Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1" T cell population./ Immunol. 157, 4421-7.
221. Vouldoukis, L, Riveros-Moreno, V., Dugas, B., Ouaaz, F., Becherel, P., Debre, P., Moncada, S., and Mossalayi, M. D. (1995). The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc. Nail. Acad. Sei. USA 92, 7804-8.
222. Waitumbi, J., and Warburg, A. (1998). Phlebotomus papatasi saliva inhibits protein phospha-tase activity and nitric oxide production by murine macrophages. Infect. Immun. 66, 1534-7.
223. Wakil, A. E., Wang, Z. E., Ryan, J. C., Fowell, D. J., and Locksley, R. M. (1998). Interferon gamma derived from CD4(+) T cells is sufficient to mediate T helper cell type 1 development.;. Exp. AW. 188, 1651-6.
224. Walker, P. S., Scharton-Kersten, T., Rowton, E. D., Hengge, U., Bouloc, A., Udey, M. C., and Vogel, J. C. (1998). Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum. Gene. Ther. 9, 1899-907.
225. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., and Bluestone, J. A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-13.
226. Wang, Z.-E., Reiner, S. L., Zheng, S., Dalton, D. K., and Locksley, R. M. (1994a). CD4+ effector cells default to the Th2 pathway in interferon /i-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367-1371.
227. Wang, Z.-E., Zheng, S., Corry, D. B., Dalton, D. K., Seder, R. A., Reiner, S. L., and Locksley, R. M. (1994b). Interferon gamma-independent effects of interleukin 12 adminis-tered during acute or established infection due to Leishtnania major. Proc. Natl. Acad. Sei. USA. 91, 12932-12936.
228. Warburg, A., and Schlein, Y. (1986). The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am. J. Trop. Med. Hyg. 35, 926-30.
229. Warburg, A., and Waitumbi, J. (1997). Sandfly saliva and leishmaniosis. Acta. Parasitai. Turc. 21 (SuppI), 67.
230. Weinheber, N., Wolfram, M., Harbecke, D., and Aebischer, T. (1998). Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28, 2467-77.
231. WHO. (1998). WHO information, by topic or disease. In "www.vho.intvhosis/topics".
232. Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A., and McGowan, S. E. (1998). The importance of TGF-beta in murine visceral leishmaniasis.y. Immunol. 161,6148-55.
233. Wolfram, M., Ilg, T., Mottram, J. C., and Overath, P. (1995). Antigen presentation by Leishmania mexicana-infected macrophages: activation of helperT cells specific for amasti-gote cysteine proteinases requires killing of die parasite. Eur. J. Immunol. 25,1094-1100.
234. Yang, D. M., Rogers, M. V., and Liew, F. Y. (1991). Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology 72, 3-9.
235. Yoshida, S., Takamatsu, T., Denda, S., Ohnuma, M., Tajima, M., Lemer, E. A., and Kanda, F. (1996). Structural characterization and location of disulphide linkages of a potent vasodilatory peptide, recombinant maxadilan, by a multiple mass spectrometric approach. Rapid Commun. Moss. Spectrom. 10, 641-8.
236. Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J., and Paul, W. E. (1995). Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production. Science 270, 1845-7.
237. Zilberstein, D., and Shapira, M. (1994). The role of pH and temperature in the development of Leishmania parasites. Ann. Rev. Microbiol. 48, 449-70.
238. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., and Heeg, K. (1998). CpG oligodeoxynucleotides trigger protective and curative Thl responses in lethal murine leishmaniasis. J. Immunol. 160, 3627-30.